文献速递糖尿病

儿童糖尿病酮症酸中毒不良结局的巢式病例对照研究

A Nested Case-Control Study of Adverse Outcomes in Children With Diabetic Ketoacidosis.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在2010-2023年4565例因糖尿病酮症酸中毒-高血糖高渗状态(DKA-HHS)入院的患儿中,109例出现不良结局。采用复合风险评分进行巢式病例对照匹配,将84例不良结局病例与84例无或较短ICU停留的对照匹配。结果显示病例组新发糖尿病更多、初始血钠和血尿素氮更高,高血糖、酸中毒和高钠血症纠正更慢,但两组在液体和胰岛素治疗总量上无差异。

要点

  • 高钠血症在入院时更常见,且在不良结局患儿治疗最初24小时内更易持续存在。
  • 病例组新发糖尿病比例更高,初始血钠和血尿素氮更高。
  • 两组在液体输注总量、12和24小时尿量及12小时胰岛素总量上无差异。

核心结论

  • 在DKA-HHS患儿中,出现不良结局者入院时更可能存在高钠血症,且高钠血症在治疗最初24小时内更易持续存在。
  • 上述差异与治疗管理差异无关。

研究设计与样本

  • 巢式病例对照研究,纳入2010-2023年4565例因DKA-HHS入院的患儿,其中109例出现不良结局。
  • 使用复合风险评分将84例不良结局病例与84例无或较短ICU停留(0-24小时)的对照进行匹配。

主要发现

  • 病例组与对照组在风险评分、初始pH、最高血糖或2型糖尿病比例上无差异。
  • 病例组新发糖尿病患者更多,初始血清钠和血尿素氮更高。
  • 病例组高血糖、酸中毒和高钠血症的纠正速度更慢。
  • 两组在12小时和24小时的总液体推注量、总液体量或尿量上无差异。
  • 12小时后总胰岛素用量两组无差异,但病例组在24小时时更可能需要继续静脉胰岛素治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adverse outcomes (death or intensive care unit [ICU] stays longer than 48 hours) in children with diabetic ketoacidosis (DKA) or hyperglycemic-hyperosmolar syndrome (HHS) can be predicted by a composite risk score based on severity of hyperglycemia and acidosis, and presence of type 2 diabetes. OBJECTIVE: Because most high-risk patients nevertheless do not experience an adverse outcome, we tried to identify differences in management or other clinical characteristics that influenced outcomes. METHODS: In a previously defined group of 4565 admissions for DKA-HHS in 2010-2023, 109 had adverse outcomes. We conducted a nested case-control study using the composite risk score to match 84 cases from the adverse outcome group with an equal number of controls without or with briefer ICU stays of 0 to 24 hours. RESULTS: The groups did not differ in risk score or initial pH, maximum blood glucose, or proportion with type 2 diabetes. However, the case group had more patients with new-onset diabetes and higher initial serum sodium and blood urea nitrogen. The case group had slower resolution of hyperglycemia, acidosis, and hypernatremia. The groups did not differ in total administered fluid bolus volumes, total fluid volumes, or urine output at 12 and 24 hours. Total insulin received did not differ between groups after 12 hours, but cases were more likely to still require intravenous insulin at 24 hours. CONCLUSION: Hypernatremia is more likely to be present at admission and to persist over the first 24 hours of treatment in children with DKA-HHS who have adverse outcomes. This is not associated with differences in management.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Yousif MF, Dolak KD, Adhikari S, et al. A Nested Case-Control Study of Adverse Outcomes in Children With Diabetic Ketoacidosis. J Clin Endocrinol Metab. 2025. PMID: 39657257. doi:10.1210/clinem/dgae848

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。